0001140361-17-014885.txt : 20170405 0001140361-17-014885.hdr.sgml : 20170405 20170405154432 ACCESSION NUMBER: 0001140361-17-014885 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170324 FILED AS OF DATE: 20170405 DATE AS OF CHANGE: 20170405 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arbutus Biopharma Corp CENTRAL INDEX KEY: 0001447028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980597776 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 BUSINESS PHONE: 604-419-3200 MAIL ADDRESS: STREET 1: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp DATE OF NAME CHANGE: 20110607 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20081003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sofia Michael J. CENTRAL INDEX KEY: 0001635324 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34949 FILM NUMBER: 17742449 MAIL ADDRESS: STREET 1: C/O ONCORE BIOPHARMA, INC. STREET 2: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 4 1 doc1.xml FORM 4 X0306 4 2017-03-24 0 0001447028 Arbutus Biopharma Corp ABUS 0001635324 Sofia Michael J. C/O ARBUTUS BIOPHARMA CORP. SUITE 100, 8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 BRITISH COLUMBIA, CANADA 0 1 0 0 Chief Scientific Officer Employee Stock Option (Right to Buy) 3.15 2017-03-24 4 A 0 150000 0 A 2027-03-24 Common Stock 150000 150000 D The options vest as follows: 1/3 on March 23, 2018; 1/3 on March 23, 2019; 1/3 on March 23, 2020. /s/ Bruce Cousins as attorney-in-fact for Michael J. Sofia 2017-04-04